Vista Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | BSE: 524711
₹10.25 
-0.45 (-4.21 %)
Last Updated: 25 Feb 2025 12:00 AM
BEARISH
Overview
Open (₹) 10.91
High (₹) 10.91
Low (₹) 10.18
Prev. Close (₹) 10.70
Volume 5,692
VWAP (₹) 10.47
ROCE (%) -9.10
Industry P/E 43.77
TTM P/E -15.30
P/B Ratio 1.19
Market Cap (₹) Cr.46.77
Dividend Yield (%)--
EPS (₹) -1.03
ROE-12.00%
Sales Growth (%) 924.99
Profit Growth (%)-20.31
Day Range
10.9110.91
52 Week Range
9.1016.59
Historical Returns
Returns (6M)
-21.15 %
Returns (1Y)
-25.18 %
Returns (3Y)
-6.39 %
Returns (5Y)
32.77 %
Returns (6M)
-21.15 %
Returns (1Y)
-25.18 %
Returns (3Y)
-6.39 %
Returns (5Y)
32.77 %
SWOT Analysis
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
Technicals
Technical Rating
BEARISHRSI 54.27
MFI 74.50
ATR 0.70
Commodity Channel Index 0.00
ROC125 -19.80
ROC21 3.64
Williams %R -88.24
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 10.72 | 11.18 | 11.45 | 10.45 | 9.99 | 9.72 | 9.26 |
| Week Ago | 11.20 | 11.69 | 12.15 | 10.74 | 10.25 | 9.79 | 9.30 |
| Month Ago | 10.77 | 11.01 | 11.47 | 10.31 | 10.07 | 9.61 | 9.37 |
EMA & SMA
10.25
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 10.71
9 Day 10.84
10 Day 10.78
12 Day 10.79
14 Day 10.80
20 Day 10.36
26 Day 10.38
50 Day 10.86
100 Day 11.55
200 Day 12.59
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| UMAKANTH KATTA | bulk | Sell | 12 Jun, 2024 | ₹13.54 | 2,61,188 | BSE |
| UMAKANTH KATTA | bulk | Sell | 10 Jun, 2024 | ₹13.33 | 7,50,979 | BSE |
| SUNDARA RAO BEHTA | bulk | Buy | 10 Jun, 2024 | ₹13.29 | 5,00,000 | BSE |
| UMAKANTH KATTA | bulk | Sell | 05 Jun, 2024 | ₹13.22 | 3,00,103 | BSE |
| MEHJABEEN SHALAM | bulk | Buy | 05 Jun, 2024 | ₹13.22 | 3,00,000 | BSE |
| MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Sell | 28 Dec, 2022 | ₹14.41 | 2,44,668 | BSE |
| MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Buy | 28 Dec, 2022 | ₹13.93 | 1,83,682 | BSE |
| NAVEEN MALVAY | bulk | Sell | 18 Apr, 2022 | ₹8.43 | 2,01,528 | BSE |
| SURESH GADALEY | bulk | Buy | 29 Dec, 2021 | ₹9.33 | 2,63,734 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 05 Aug, 2021 | Dhananjaya Alli | Acquisition | ₹2.00 | 10,07,391 | BSE |
| 22 Mar, 2021 | Dhananjaya Alli | Acquisition | ₹2.00 | 14,00,000 | BSE |
| 06 Aug, 2020 | Anand Chittajallu | Acquisition | ₹2.00 | 14,28,570 | BSE |
| 06 Aug, 2020 | Umakanth Katta | Acquisition | ₹2.00 | 28,57,144 | BSE |
| 15 Jul, 2020 | Umakanth Katta | Acquisition | ₹2.00 | 10,71,428 | BSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 25 Feb, 2025 | BSE India | Notice of the Extra Ordinary General Meeting of the company to be held on 20.03.2025 |
| 19 Feb, 2025 | BSE India | Outcome of Board meeting under regulation 30 of SEBI (Listing obligation and disclosure requirement Regulation), 2015 |
| 14 Feb, 2025 | BSE India | VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/02/2025 ,inter alia, to consider and approve 1. The proposal of raising of funds by way of issue of equity or convertible warrants on preferential basis, subject to the receipt of necessary approvals/permissions.\r\n\r\n2. To approve the Notice of the Extraordinary General Meeting for the approval of raising of funds.\r\n\r\n3. Any other business with the permission of the Chair.\r\n |
| 12 Feb, 2025 | BSE India | Integrated Filling for the quarter ended 31.12.2024 |
| 12 Feb, 2025 | BSE India | Outcome of the Board meetings for Approval of Unaudited financial results for the quarter ended 31.12.2024 |
| 03 Feb, 2025 | BSE India | VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve 1. Un-Audited financial results for the quarter ended 31.12.2024.\r\n2. Limited Review Report for quarter ended 31.12.2024.\r\n3. Any other business with the permission of the Chair. |
| 20 Jan, 2025 | BSE India | Compliance Certificate under reg 74 (5) of SEBI (DP) Regulations, 2018 |
| 14 Nov, 2024 | BSE India | Intimation under Regulation 30 of SEBI (LODR) Regulation 2015 - \Issue of World Health Organisation (WHO) G.M.P Certificate |
| 13 Nov, 2024 | BSE India | outcome of the Board Meeting under Regulation 30 read with 33 (3) of SEBI (LODR) Regulation 2015 |
| 07 Nov, 2024 | BSE India | VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve 1. Un Audited financial results for the quarter ended 30.09.2024.\r\n2. Limited Review Report for quarter ended 30.09.2024\r\n3. Any other business with the permission of the Chair.\r\n |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Preferential Issue of shares & Others | Inter-alia, to consider 1. Notice of the EGM for the approval of raising of funds. 2. Other business matters. | 20 Feb, 2025 | 19 Feb, 2025 |
| Quarterly Results | -- | 04 Feb, 2025 | 12 Feb, 2025 |
| Quarterly Results | -- | 08 Nov, 2024 | 13 Nov, 2024 |
| Quarterly Results | -- | 06 Aug, 2024 | 13 Aug, 2024 |
| Audited Results | -- | 22 May, 2024 | 28 May, 2024 |
| Quarterly Results | -- | 05 Feb, 2024 | 10 Feb, 2024 |
| Quarterly Results | -- | 06 Nov, 2023 | 10 Nov, 2023 |
| Quarterly Results | -- | 09 Aug, 2023 | 12 Aug, 2023 |
| Audited Results | -- | 24 May, 2023 | 30 May, 2023 |
| Quarterly Results | -- | 08 Feb, 2023 | 13 Feb, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Vista Pharmaceuticals
Vista Pharmaceuticals is a Public Limited Listed company incorporated on 25/01/1991 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24239TG1991PLC012264 and registration number is 012264. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 10.29 Cr. and Equity Capital is Rs. 9.43 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1991
Managing Director
Mr. Murali Meraga
NSE Symbol
--
Vista Pharmaceuticals Management
| Name | Designation |
|---|---|
| Dr. Dhananjaya Alli | Chairman & Wholetime Director |
| Mr. Murali Meraga | Managing Director |
| Mr. Pavan Sathvik Gilaka | Whole Time Director |
| Mr. Divakar Reddy Yerrabommanahalli | Non Executive Director |
| Mr. Stanley Prabhakar Reddy | Non Executive Director |
| Mr. Mallem Hanumantha Rao | Non Executive Director |
| Mr. Umakanth Katta | Non Executive Director |
| Dr. Umesh Virupakah Banakar | Independent Director |
| Ms. Divya Bhavani Chakravarthula | Independent Director |
| Mr. Naga Raja Madineni | Independent Director |
| Mr. Madhu Sudan Anchi | Independent Director |
| Mrs. Swapna Priya Gunduboina | Independent Director |
| Mr. Anumala Ravi Chandra kumar | Independent Director |
| Mr. Rama Mohan Manamasa | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,613.60  ₹1,639.50(-1.58%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,726.40  ₹5,702.55(0.42%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,463.35 ₹1,476.75(-0.91%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,342.10 ₹2,298.80(1.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,128.15 ₹1,164.55(-3.13%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Vista Pharmaceuticals
What is the share price of Vista Pharmaceuticals?
The share price of Vista Pharmaceuticals on 25 Feb, 2025 is ₹ 10.25.
What is 52W high and 52W low share price of Vista Pharmaceuticals?
The highest and lowest 52W share prices of Vista Pharmaceuticals are ₹ 17.550 and ₹ 10.430
What is the market cap of Vista Pharmaceuticals?
The market capitalization of Vista Pharmaceuticals as of 25 Feb, 2025 is ₹ 46.77 Crores
What is the P/E ratio of Vista Pharmaceuticals?
The current P/E ratio of Vista Pharmaceuticals as of 25 Feb, 2025 is 43.77
What is the PB ratio of Vista Pharmaceuticals?
The PB ratio of Vista Pharmaceuticals as of 25 Feb, 2025 is 1.19
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)